Skip to content

Dependence on Analgesics in Chronic Non-cancer Pain

Dependence on Analgesics in Chronic Non-cancer Pain: Comparison of the Perceptions of the Algologist Physician and the Perception of the Patient.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03346408
Acronym
DISCORDANCE
Enrollment
220
Registered
2017-11-17
Start date
2017-11-04
Completion date
2018-12-18
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Chronic

Keywords

Analgesics

Brief summary

The identification of an addiction to opioid analgesics has become strong recommendation for the purpose of improving the clinical management of the patients. However, the success of the patient's clinical management, in terms of analgesia and treatment of drug dependence, rests on the acceptance of this management by the patient himself. The main objective of this study is to evaluate the factors associated to the discrepancy between the assessment of dependence on analgesic drugs by the algologist and the perception that the patient with non-cancer chronic pain has of this dependence.

Detailed description

The long-term use of opioid analgesics for the treatment of chronic non-cancer pain exposes patients to the risk of developing drug dependence on these psychoactive drugs with loss of control of their use. In general medicine as well as in algology consultation, the identification of an addiction to opioid analgesics (and even misuse as a gateway to addiction) have thus become strong recommendations for the purpose of improving the management of the patients. However, the success of the patient's clinical management, in terms of analgesia and treatment of drug dependence, rests on the acceptance of this management by the patient himself. The discrepancy between the assessment of drug dependence on analgesic drugs by the algologist and the perception that the patient has of this dependence will be investigated through a multicentre cross-sectional descriptive survey performed in pain treatment centres in France. In addition to opioid analgesics, other pharmacological classes used for analgesic use will be investigated as they are concerned with the development of drug dependence. This is particularly the case for gabapentins.

Interventions

BEHAVIORALQuestionnaire

patient (self-questionnaire) and algologist physician (questionnaire)

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* suffering from chronic non-cancer pain, * taking at least one analgesic medication

Exclusion criteria

* Patient minor or major protected by the law (under tutelage), * Patient with chronic pain of cancerous origin, * Opposition of the patient to be included in the study, * Patient not having the overall skills to complete a self-questionnaire: major difficulties in understanding the French language and / or reading / writing difficulties.

Design outcomes

Primary

MeasureTime frameDescription
discrepancy between the assessment of dependence on analgesic drugs by the algologist and the perception of the patientBaselineThe patients will complete a self-questionnaire and the algologist physician will fill another questionnaire.

Secondary

MeasureTime frameDescription
Consumption drugsBaselinePatient questionnaire for associated drug
AnxietyBaselineHospital Anxiety and Depression Scale (HAD Scale)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026